The Hemophilia Alliance will be presenting a special webinar on understanding the difference between Copay Accumulators, Copay Maximizers, and Alternative Funding Programs. This webinar will be held on July 11 at 1:00pm EST. Click here to register.

In this comprehensive session, attendees will gain a deep understanding of three critical elements of the difference between patient access barriers: copay accumulators, copay maximizers, and alternative funding programs. This talk will demystify these concepts, explain how each mechanism operates, their impact on patients’ out-of-pocket costs, and the broader implications for patients, providers and insurers.

By the end of this session, attendees will be equipped with the knowledge and tools to better understand the nuances of copay accumulators, copay maximizers, and alternative funding programs. They will leave with actionable strategies to support patients in managing their out-of-pocket costs while maintaining access to essential medications.

Speakers:

Becky Burns COO & CFO of the Bleeding and Clotting Disorders Institute, Peoria, IL Click here to learn more about Becky.

Kollet Koulianos Hemophilia Alliance Payer Relations Consultant Click here to learn more about Kollet.

by Heidi Lane (Chair, PT Meeting Committee)

This May the first annual Hemophilia Alliance Physical Therapy CE Conference in Denver, Colorado was held, and all attending felt it was a resounding success. Forty-two physical therapists from member HTCs across the country, including Hawaii, were in attendance. The conference featured a combination of didactic sessions and hands-on labs, with ample time for discussion and sharing of best practices. Topics included a 340B overview, the Hemophilia Joint Health Score (HJHS), use of orthotics as a PT intervention, the importance of rest in acute bleed management, and point of care musculoskeletal ultrasound (MSKUS) for joint health assessment.

The networking opportunities for new and seasoned therapists enriched the learning experience, fostered a sense of community and left attendees feeling rejuvenated to head back to their respective HTCs. Over 90% of attendees reported being “very satisfied” with the conference and when surveyed about their single favorite part of the meeting, more than 50% of attendees reported “networking” and another 20% reported the “lab/lecture” format. A big thank you to the Hemophilia Alliance Team that planned and supported the conference, Sanofi, the Denver Hemophilia Treatment Center, the planning committee, and session speakers for this great opportunity for professional development and networking!